Search results
Your search for ���������������������������������Talk:PC53��� returned no results
Showing 166 to 180 of 185 results for ���������������������������������talk���
Showing 166 to 180 of 185 results for ���������������������������������talk���
New treatment for cardiovascular disease could benefit millions
Up to 2.1 million people with cardiovascular disease (CVD) could benefit from a new cholesterol target outlined in NICE guidance for the first time.
Around 1,500 people aged 12 years and over with melanoma are set to benefit from pembrolizumab, a drug that reduces the chance of it returning.
committees and how you can get involved. Other ways to listen Our NICE talks podcasts are available on a variety of different platforms...
We have also recommended osimertinib for routine use on the NHS today.
Updated menopause guidance includes discussion aid to support conversations about HRT
Our updated guideline on menopause emphasises the importance of an individualised approach and shared decision-making when making choices about treatment for symptoms.
NICE responds to failure of talks to reach price agreement on Enhertu
Talks with the makers of Enhertu have ended without agreement, meaning guidance that does not recommend Enhertu for advanced breast cancer will remain unchanged.
NICE launches refreshed support service for life sciences industry
NICE has launched its refreshed support service for the life sciences sector, NICE Advice.
To mark Time to Talk Day (February 2) we spoke with Catherine Ruane, who acted as a carer for her father and sister, who both lived with depression.
NICE's deputy chief executive, Jonathan Benger, talks about our new approach to prioritisation.
This International Women’s Day, we’re focusing on the invaluable contributions of 2 of the women who help shape our guidance through their independent voluntary committee roles. They talk to us about their involvement with NICE and what #InspireInclusion means to them.
NICE leads the way to develop a new approach to routinely value and pay for crucial antimicrobials
James Love-Koh talks about the next steps for the 3-year project to develop a routine framework for evaluating and paying for new antimicrobials.
25 years of NICE and focusing on what matters most to deliver for the future
Institute for Applied Data Science Ben Goldacre. Other ways to listen Our NICE talks podcasts are available on a variety of different...
ovarian cancer Podcasts 03 April 2024 Listen About this episode We talk to Ranjit Manchanda, professor of gynaecological oncology, Queen...
Learn more about the NICE and NHS England MedTech Pathway consultation
opportunities the proposed pathway will offer. Other ways to listen Our NICE talks podcasts are available on a variety of different...
Learn more about NICE's new guideline on identifying and managing adrenal insufficiency
to patients and healthcare professionals. Other ways to listen Our NICE talks podcasts are available on a variety of different platforms...